Yang Luo Selected Research

Trastuzumab (Herceptin)

7/2021	Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial.
1/2021	Primary Trastuzumab Resistance After (Neo)adjuvant Trastuzumab-containing Treatment for Patients With HER2-positive Breast Cancer in Real-world Practice.
1/2020	Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab.
10/2019	Trastuzumab plus adjuvant chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive early-stage breast cancer: A real-world retrospective study in Chinese patients.
1/2019	Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis.
1/2019	Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab.
1/2019	Pharmacokinetics of pertuzumab administered concurrently with trastuzumab in Chinese patients with HER2-positive early breast cancer.
2/2013	[Long-term efficacy and safety of adjuvant trastuzumab for HER2-positive early breast cancer].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yang Luo Research Topics

Disease

138	Neoplasms (Cancer) 05/2024 - 04/2002
66	Breast Neoplasms (Breast Cancer) 03/2024 - 06/2012
29	Inflammation (Inflammations) 12/2023 - 07/2010
28	Neoplasm Metastasis (Metastasis) 01/2024 - 06/2007
23	Colorectal Neoplasms (Colorectal Cancer) 02/2024 - 09/2007
19	Triple Negative Breast Neoplasms 02/2024 - 01/2015
19	Infections 05/2023 - 01/2014
13	Urinary Bladder Neoplasms (Bladder Cancer) 03/2024 - 11/2013
11	Stomach Neoplasms (Stomach Cancer) 01/2023 - 06/2007
10	Atopic Dermatitis (Atopic Eczema) 12/2023 - 01/2019
8	COVID-19 11/2023 - 01/2020
8	Carcinogenesis 01/2023 - 02/2011
8	Carcinoma (Carcinomatosis) 01/2022 - 12/2003
7	Pain (Aches) 04/2022 - 11/2015
6	Intervertebral Disc Degeneration 03/2024 - 08/2013
6	Wounds and Injuries (Trauma) 10/2023 - 01/2013
6	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 07/2008
6	Lymphatic Metastasis 09/2023 - 09/2007
6	Lung Neoplasms (Lung Cancer) 09/2023 - 09/2016
6	Spinal Cord Injuries (Spinal Cord Injury) 01/2023 - 11/2015
6	Cicatrix (Scar) 01/2023 - 10/2013
6	Disease Progression 01/2023 - 11/2013
6	Cognitive Dysfunction 01/2022 - 01/2020
5	Dermatitis 12/2023 - 01/2019
5	Stroke (Strokes) 01/2022 - 01/2014
4	Osteoporosis 03/2024 - 01/2017
4	Melanoma (Melanoma, Malignant) 01/2024 - 03/2016
4	Obesity 11/2023 - 10/2019
4	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2022 - 01/2020
4	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 10/2012
4	Thrombocytopenia (Thrombopenia) 01/2022 - 05/2018
4	Neutropenia 01/2022 - 10/2015
4	Skin Diseases (Skin Disease) 01/2022 - 06/2014
4	Necrosis 11/2020 - 11/2015
4	Ulcerative Colitis 10/2020 - 01/2016
4	Colitis 10/2020 - 01/2016
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020 - 01/2014
3	Atherosclerosis 02/2024 - 01/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2019

Drug/Important Bio-Agent (IBA)

49	Proteins (Proteins, Gene)FDA Link 11/2023 - 02/2009
29	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2011
14	Hormones (Hormone)IBA 08/2023 - 01/2015
13	MicroRNAs (MicroRNA)IBA 04/2023 - 01/2011
13	AnthracyclinesIBA 01/2022 - 09/2014
12	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 12/2013
11	Capecitabine (Xeloda)FDA Link 12/2023 - 01/2015
11	RNA (Ribonucleic Acid)IBA 11/2023 - 04/2004
11	Cyclin G2IBA 12/2022 - 06/2002
10	human ERBB2 proteinIBA 02/2021 - 01/2015
9	VaccinesIBA 01/2023 - 11/2013
9	Indicators and Reagents (Reagents)IBA 06/2022 - 11/2007
8	CytokinesIBA 05/2024 - 09/2011
8	EnzymesIBA 11/2023 - 07/2016
8	ErbB Receptors (EGF Receptor)IBA 01/2022 - 10/2016
8	Trastuzumab (Herceptin)FDA Link 07/2021 - 02/2013
8	Taxoids (Taxanes)IBA 03/2021 - 01/2015
7	Messenger RNA (mRNA)IBA 10/2023 - 01/2008
7	Epirubicin (Ellence)FDA LinkGeneric 01/2023 - 01/2014
7	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2015
6	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2022
6	Circular RNAIBA 10/2023 - 01/2021
6	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 12/2003
6	Interleukin-6 (Interleukin 6)IBA 01/2023 - 09/2011
6	Vinorelbine (Navelbine)FDA LinkGeneric 01/2023 - 10/2015
6	CateninsIBA 01/2022 - 03/2013
5	LipidsIBA 02/2024 - 10/2012
5	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024 - 01/2021
5	LigandsIBA 12/2023 - 02/2009
5	pyrotinibIBA 12/2023 - 09/2017
5	Small Interfering RNA (siRNA)IBA 11/2022 - 06/2007
5	Monoclonal AntibodiesIBA 10/2022 - 10/2016
5	Therapeutic UsesIBA 06/2022 - 11/2015
5	PlatinumIBA 01/2022 - 10/2015
5	Long Noncoding RNAIBA 01/2022 - 10/2015
5	Caspase 3 (Caspase-3)IBA 01/2021 - 01/2018
5	taxaneIBA 01/2018 - 10/2015
4	AntibodiesIBA 04/2024 - 01/2008
4	Tyrosine Kinase InhibitorsIBA 02/2023 - 09/2017
4	Antiviral Agents (Antivirals)IBA 12/2022 - 11/2015
4	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 01/2014
4	Estrogen ReceptorsIBA 07/2022 - 09/2014
4	Phenobarbital (Luminal)FDA Link 02/2022 - 01/2014
4	AntioxidantsIBA 01/2022 - 11/2015
4	Progesterone Receptors (Progesterone Receptor)IBA 10/2021 - 09/2014
4	Estrogens (Estrogen)FDA Link 01/2021 - 06/2007
4	Sincalide FDA Link 01/2021 - 12/2014
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2009
4	Aromatase InhibitorsIBA 01/2020 - 07/2015
4	AcidsIBA 07/2018 - 10/2013
4	Cadherins (E-Cadherin)IBA 07/2016 - 04/2002
3	Phosphotransferases (Kinase)IBA 05/2024 - 11/2016
3	HydrogelsIBA 01/2024 - 01/2021

Therapy/Procedure

62	Therapeutics 04/2024 - 02/2013
39	Drug Therapy (Chemotherapy) 02/2024 - 06/2012
12	Immunotherapy 12/2023 - 01/2021
11	Neoadjuvant Therapy 01/2024 - 01/2014
9	Adjuvant Chemotherapy 01/2023 - 03/2013
7	Renal Dialysis (Hemodialysis) 01/2023 - 01/2020
6	Transplantation 12/2023 - 01/2019
4	Length of Stay 09/2019 - 10/2016